Stock Earnings

Question 1

What are Larimar Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Larimar Therapeutics Inc has a total asset of $200, Net loss of $-80

Question 2

What are the key financial ratios for LRMR?

Accepted Answer

Larimar Therapeutics Inc's Current ratio is 7.14, has a Net margin is 0, sales per share of $0.

Question 3

How is Larimar Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Larimar Therapeutics Inc data is not available.

Question 4

Is Larimar Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Larimar Therapeutics Inc has a net loss of $-80

Question 5

Does Larimar Therapeutics Inc have any liabilities?

Accepted Answer

yes, Larimar Therapeutics Inc has liability of 28

Question 6

How many outstanding shares for Larimar Therapeutics Inc?

Accepted Answer

Larimar Therapeutics Inc has a total outstanding shares of 63.81

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	17	17	14	12	12	11
Research & Development	90	73	27	24	38	31
Operating Expenses	108	90	41	36	50	42
Other Non Operating Income (Expenses)	8	10	4	1	0	0
Pretax Income	-99	-80	-36	-35	-50	-42
Income Tax Expense	--	0	--	--	--	--
Net Income	-99	-80	-36	-35	-50	-42
Net Income Growth	71%	122%	3%	-30%	19%	-7%
Shares Outstanding (Diluted)	64.02	61.25	43.9	25.76	17.16	11.88
Shares Change (YoY)	0%	40%	70%	50%	44%	282%
EPS (Diluted)	-1.55	-1.32	-0.84	-1.37	-2.95	-3.57
EPS Growth	71%	56.99%	-39%	-54%	-17%	-76%
Free Cash Flow	-92	-71	-33	-27	-42	-42
Free Cash Flow Per Share	-1.43	-1.15	-0.75	-1.04	-2.44	-3.53
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-108	-90	-41	-36	-50	-42
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-108	-90	-41	-36	-50	-42
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Larimar Therapeutics Inc (LRMR) Price